Latest debt-to-equity ratio
Rhythm Pharmaceuticals Debt-to-equity ratio
Direct answer
Rhythm Pharmaceuticals's debt-to-equity ratio is 50.52%.
The verified market snapshot reports 50.52%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 11, 2026.
Get free Rhythm Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 50.52%
Explore related company data
View Rhythm Pharmaceuticals's market capitalizationView Rhythm Pharmaceuticals's price-to-book ratioView Rhythm Pharmaceuticals's return on equityView Rhythm Pharmaceuticals's dividend yieldView Rhythm Pharmaceuticals's 52-week price rangeView Rhythm Pharmaceuticals's revenue growthView Rhythm Pharmaceuticals's profit marginView all Rhythm Pharmaceuticals key metricsReturn to Rhythm Pharmaceuticals profile